Benjamin Herbage, Deputy Managing Director at SYMATESE lectured today on HA NEW HA FILLER TECHNOLOGIES: WHAT BENEFIT FOR YOU AND YOUR PATIENTS and highlighted C-HA PURE TECHNOLOGY by SymateseTM, the 1st generation cold crosslinking technology developed by Symatese: a pioneering and gentler crosslinking technology, supported by a robust global clinical development program.